Insulet stock underperformed the broader market on August 7, 2025.
1 report, 1 independent
Updated Aug 7
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Insulet stock underperformed the broader market on August 7, 2025.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Insulet (United States)
insulin delivery device company
Nothing else this week.
Coverage
Newest first; wire copies grouped- ZacksInsulet (PODD) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates Insulet (PODD) reported $649.1 million in revenue for the quarter ended June 2025, representing a year-over-year increase of